Washington Trust Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.29M Buy
70,141
+1,080
+2% +$125K 0.62% 42
2026
Q1
$8.25M Buy
69,061
+4,221
+7% +$554K 0.67% 41
2025
Q4
$8.83M Sell
64,840
-415
-0.6% -$59.7K 0.67% 43
2025
Q3
$9.63M Buy
65,255
+1,238
+2% +$172K 0.73% 37
2025
Q2
$8.28M Buy
64,017
+1,047
+2% +$127K 0.67% 42
2025
Q1
$7.52M Buy
62,970
+3,155
+5% +$391K 0.67% 43
2024
Q4
$6.94M Buy
59,815
+50,078
+514% +$6.33M 0.58% 46
2024
Q3
$1.31M Buy
9,737
+64
+0.7% +$8.56K 0.11% 87
2024
Q2
$1.31M Buy
9,673
+71
+0.7% +$9.66K 0.12% 83
2024
Q1
$1.24M Buy
9,602
+50
+0.5% +$6.04K 0.11% 81
2023
Q4
$1.09M Hold
9,552
0.1% 88
2023
Q3
$870K Hold
9,552
0.09% 99
2023
Q2
$1.08M Hold
9,552
0.1% 92
2023
Q1
$1M Hold
9,552
0.1% 94
2022
Q4
$1.06M Hold
9,552
0.12% 93
2022
Q3
$834K Hold
9,552
0.08% 107
2022
Q2
$747K Hold
9,552
0.07% 108
2022
Q1
$814K Hold
9,552
0.06% 119
2021
Q4
$1.15M Buy
+9,552
New +$1.19M 0.08% 108

Other funds holding XYL

Washington Trust Advisors's XYL Position: Q2 2026 in Review

Washington Trust Advisors increased its Xylem (XYL) stake by 1.6% in Q2 2026, buying an estimated $125K and bringing the position to 70,141 shares worth $8.29M. The position accounts for 0.62% of the portfolio, ranked #42.

Washington Trust Advisors first reported a position in XYL in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.63M in Q3 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Washington Trust Advisors held 70,141 shares of Xylem worth $8.29M as of Q2 2026.
  • Washington Trust Advisors bought 1,080 Xylem shares in Q2 2026, an estimated $125K.
  • Xylem made up 0.62% of Washington Trust Advisors's portfolio in Q2 2026, its #42 holding.
  • Washington Trust Advisors first reported a position in Xylem in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Xylem position peaked at $9.63M in Q3 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.